Skip to content
WeighLab

MadeMed vs Collective

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

MadeMed

Provider comparison

Shoppers comfortable paying three months at a time who want one flat price at every dose, or a no-needle sublingual semaglutide tablet.

Semaglutide / month
$239/moQuarterly plan, billed $717 every 3 months, same price at every dose, compounded
Tirzepatide / month
$399/moQuarterly plan, billed $1,197 every 3 months, same price at every dose, compounded
Index 68/100 · Grade CChecked October 2026

Collective

Affiliate partner

Shoppers who will stay on treatment for a full year, where the annual membership divides down over twelve months rather than landing on one.

Semaglutide / month
$59/moFor the medication, plus a required $199/year membership billed separately
Tirzepatide / month
$69/moFor the medication, plus the same required $199/year membership
Index 65/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

MadeMed has the higher Cost-Efficiency Index: 68/100 versus 65/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

MadeMed
23 states
Collective
44 states (not AL, CA, LA, MA, MS or WA)

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

MadeMed

Collective

Semaglutide / month
MadeMed: $239/moQuarterly plan, billed $717 every 3 months, same price at every dose, compounded
Collective: $59/moFor the medication, plus a required $199/year membership billed separately
Tirzepatide / month
MadeMed: $399/moQuarterly plan, billed $1,197 every 3 months, same price at every dose, compounded
Collective: $69/moFor the medication, plus the same required $199/year membership
Semaglutide / year (modeled)
MadeMed: $2,868
Collective: $907Includes $199/yr membership
Tirzepatide / year (modeled)
MadeMed: $4,788
Collective: $1,027Includes $199/yr membership
State availability
MadeMed: 23 states
Collective: 44 states (not AL, CA, LA, MA, MS or WA)
Oral / sublingual option listed
MadeMed: Yes
Collective: Not listed
Brand-name access listed
MadeMed: Not confirmed
Collective: Not confirmed
Provider facts checked
MadeMed: October 2026
Collective: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

MadeMed

Shoppers comfortable paying three months at a time who want one flat price at every dose, or a no-needle sublingual semaglutide tablet.

Reasons to consider it

  • One flat price at every dose, printed dose by dose on each product page
  • Offers sublingual semaglutide tablets ($219 a month quarterly) and oral tirzepatide alongside the injections
  • You can cancel or pause in one click from your dashboard, and it emails you 7 days before every charge

What to weigh up

  • There is no monthly plan; the shortest commitment is three months, billed up front
  • Injectable semaglutide is offered in only 23 states, fewer than the 40 the service lists overall, so check your state on the product page
  • All sales are final, and if you aren't prescribed you're refunded minus a $39 doctor visit fee

Collective

Shoppers who will stay on treatment for a full year, where the annual membership divides down over twelve months rather than landing on one.

Reasons to consider it

  • Both figures are medication prices rather than a care fee with the drug billed on top, and both appear before any intake
  • The membership covers unlimited doctor messaging, check-ins, dose adjustments, nutrition support and express cold shipping, all itemized
  • A 21-day free trial precedes the first membership charge, and the trial's auto-conversion is stated plainly

What to weigh up

  • The headline "Get GLP-1s at $59/month" leaves out the mandatory $199 annual membership, which appears only in a card panel, a small disclaimer and the FAQ
  • The membership is annual and auto-renewing, and all membership fees are non-refundable with no partial-period refund — so the cheapest medication price here cannot be bought for one month
  • The terms reserve an unpriced "nominal, uniform technology transaction fee for each electronic prescription transmission" while the homepage promises no hidden costs

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

MadeMedCollective
Normalized Cost/Month
MadeMed:
51/100
Collective:
66/100
Price Transparency
MadeMed:
97/100
Collective:
72/100
Nationwide Access
MadeMed:
52/100
Collective:
66/100
Formulation Options
MadeMed:
77/100
Collective:
66/100
Clinical Oversight
MadeMed:
87/100
Collective:
65/100
Contract Flexibility
MadeMed:
43/100
Collective:
43/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.